Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 23, 2019
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
Marc Goodman Upgraded (BIIB) to Buy and Increased Target to $350 on, Oct 23rd, 2019
Marc Goodman of SVB Leerink, Upgraded "Biogen Inc." (BIIB) to Buy and Increased Target from $256 to $350 on, Oct 23rd, 2019.
Marc has made no other calls on BIIB in the last 4 months.
There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, all agrees with Marc's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $250 on, Friday, June 28th, 2019
Similar Stocks and Investing Articles
[ Fri, Oct 11th 2019
] - WOPRAI
[ Tue, Oct 01st 2019
] - WOPRAI
[ Mon, Sep 23rd 2019
] - WOPRAI
[ Fri, Aug 02nd 2019
] - WOPRAI
[ Wed, Jul 24th 2019
] - WOPRAI
[ Fri, Jun 28th 2019
] - WOPRAI
[ Wed, May 08th 2019
] - WOPRAI
[ Mon, Jul 27th 2015
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI